FindTrial
Sign In

A study to evaluate the performance of the non-invasive hemodynamic monitor HemoVistaTM (BiLab Co. Ltd. Korea) and improve the algorithm in patients who underwent liver transplantation: a prospective observational study

A study to evaluate the performance of the non-invasive hemodynamic monitor HemoVistaTM (BiLab Co. Ltd. Korea) and improve the algorithm in patients who underwent liver transplantation: a prospective observational study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0009069
Enrollment
80
Registered
2023-12-22
Start date
2024-01-29
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Asan Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients who underwent liver transplant surgery 2. Patients undergoing postoperative hemodynamic monitoring in the surgical intensive care unit (SICU) after liver transplant surgery 3, Adult patients over 20 years old but under 80 years old

Exclusion criteria

Exclusion criteria: 1. Clinically significant arrhythmia (e.g. atrial fibrillation) that may affect stroke volume calculations 2. Patients with a cardiac pacemaker or defibrillator 3. Patients using mechanical circulatory support devices such as arteriovenous extracorporeal oxygenation (VA-ECMO) or intra-aortic balloon pump (IABP) before surgery. 4. Other people deemed unsuitable by researchers

Design outcomes

Primary

MeasureTime frame
cardiac output—

Secondary

MeasureTime frame
stroke volume—

Countries

Korea, Republic of

Contacts

Public ContactByung-Moon Choi

Asan Medical Center

rios76@hanmail.net+82-2-3010-1704

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026